Trisomy 21 and congenital heart disease: effect of timing of initial echocardiogram

Area of Science:

• Pediatric Cardiology
• Genetics
• Neonatal Health

Background:

• Infants with Down syndrome (trisomy 21) are typically recommended an echocardiogram within the first month of life.
• The optimal timing for this cardiac screening in asymptomatic infants remains a subject of investigation.

Purpose of the Study:

• To compare outcomes and the presence of transient shunting in infants with trisomy 21 based on the timing of their initial echocardiogram.
• To evaluate if early echocardiograms (Group I) versus later echocardiograms (Group II) impact key clinical outcomes.

Main Methods:

• Retrospective analysis of infants diagnosed with trisomy 21.
• Comparison of infants who underwent echocardiography within the first month of life (Group I) versus those scanned later (Group II).
• Assessment of outcomes including transient patent ductus arteriosus, patent foramen ovale, follow-up compliance, and surgical mortality.

Main Results:

• Transient patent ductus arteriosus was observed more frequently in Group I (early echocardiogram).
• No significant differences were found between the groups regarding the presence of patent foramen ovale, failure to attend follow-up appointments, or surgical mortality rates.
• Infants with trisomy 21 did not show improved outcomes with echocardiograms performed within the first month of life compared to later screening.

Conclusions:

• The timing of the initial echocardiogram in asymptomatic infants with trisomy 21 may not significantly alter major clinical outcomes.
• A more selective approach to scheduling early echocardiograms in this population could be considered.
• Further research may refine guidelines for cardiac screening in infants with Down syndrome.